Werewolf Therapeutics' (HOWL) an 'Attractive Investment Opportunity'- Citizens
Tweet Send to a Friend
Citizens analyst Reni Benjamin reiterated a Market Outperform rating and $3.00 price target on Werewolf Therapeutics Inc. (NASDAQ: HOWL).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
